Patents by Inventor Anna Sípos

Anna Sípos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors
    Patent number: 11091490
    Abstract: The present invention relates to 3-amino-pyrazolo[3,4-d]pyrimidin-4-ones, such as for example, N-{4-[1-(2,6-dichloro-4-sulfamoyl-phenyl)-3-dimethylamino-4-oxo-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-ylmethyl]-phenyl}-2-diethylamino-acetamide, particularly useful as cyclin dependent kinase (CDK) inhibitors, pharmaceutical compositions comprising the same and the use thereof in particular in the prophylaxis and/or treatment of cancer and other proliferative diseases. Furthermore, the present invention relates to processes for the synthesis of said 3-aminopyrazolo[3,4d]pyrimidin-4-ones and intermediates to be used in the processes of the present invention.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: August 17, 2021
    Assignees: MEDIZINISCHE UNIVERSITÄT INNSBRUCK, Vichem Chemie Kutató Korlátolt Felelösségü Társaság
    Inventors: Winfried Wunderlech, Lukas A. Huber, Johann Jakob Leban, János Pató, László Örfi, Wáczek Frigyes, Péter Bánhegyi, Anna Sípos, Csaba Szántai-kis
  • 3-AMINO-1,5-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONES AS CYCLIN DEPENDENT KINASE INHIBITORS
    Publication number: 20200247809
    Abstract: The present invention relates to 3-amino-pyrazolo[3,4-d]pyrimidin-4-ones particularly useful as cyclin dependent kinase (CDK) inhibitors, pharmaceutical compositions comprising the same and the use thereof in particular in the prophylaxis and/or treatment of cancer and other proliferative diseases. Furthermore the present invention relates to processes for the synthesis of said 3-amino-pyrazolo[3,4d]pyrimidin-4-ones and intermediates to be used in the processes of the present invention.
    Type: Application
    Filed: November 29, 2017
    Publication date: August 6, 2020
    Applicants: Oncotyrol Center for Personalized Cancer Medicine GMBH, Vichem Chemie Kutató Korlátolt Felelösségü Társaság
    Inventors: Winfried Wunderlech, Lukas A. Huber, Johann Jakob Leban, János Pató, László Örfi, Wáczek Frigyes, Péter Bánhegyi, Anna Sípos, Csaba Szántai-kis